Zahra Mahmoudjafari, PharmD, BCOP, DPLA, opens a discussion surrounding chronic lymphocytic leukemia (CLL).
Back
The Use of Combination Therapies in the Frontline Setting for CLL
Expert, Zahra Mahmoudjafari, PharmD, BCOP, DPLA shares insights on the expanding treatment landscape for CLL.
The Use of Combination Therapies in the Frontline Setting for CLL
Episodes
All
All
Dr Mahmoudjafari highlights the changing treatment landscape for patients with CLL.
CAPTIVATE FD and GLOW studies results and takeaways are discussed by Dr Mahmoudjafari.
Dr Mahmoudjafari explores the role of BTK inhibitors in the treatment of CLL.
In her closing thoughts, Dr Mahmoudjafari provides an overview of cardiovascular implications associated with CLL as well as the impact of pharmacists in CLL treatment management.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Closing the Calcium Gap: How Pharmacists Can Guide Patients Toward Better Bone Health
2
COVID-19 Vaccination in Medically Complex Adults
3
Testing categories in practice — clinical conversations
4
The Vaccine Schedule Just Changed Again—Here’s What's Real and What Isn't
5